Legal basis of the Advanced Therapies Regulation

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
V JekerleE Pedone

Abstract

Advanced therapy medicinal products consist of gene therapy, somatic cell therapy and tissue engineered products. Due to their specific manufacturing process and mode of action these products require specially tailored legislation. With Regulation (EC) No. 1394/2007, these needs have been met. Definitions of gene therapy, somatic cell therapy and tissue engineered products were laid down. A new committee, the Committee for Advanced Therapies, was founded, special procedures such as the certification procedure for small- and medium-sized enterprises were established and the technical requirements for Marketing Authorisation Applications (quality, non-clinical and clinical) were revised.

Citations

Aug 13, 2013·Regulatory Toxicology and Pharmacology : RTP·M KooijmanH Schellekens
May 9, 2016·Biologicals : Journal of the International Association of Biological Standardization·Kuni Itoh, Shingo Kano

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.